Important Notice

This site is for informational purposes only and is intended to address unsolicited medical questions by healthcare professionals based in the United States. This resource may contain medical and scientific information about Celgene products uses that have not been approved by the United States Food and Drug Administration.

If you are not a healthcare professional, please discuss any questions you have regarding your health or treatment with your health care provider.

Celgene is now part of Bristol Myers Squibb.

By clicking continue, you are acknowledging that you are a US-based healthcare professional.

CONTINUE

If you are not a US-based healthcare professional

CLICK HERE

You are now leaving CelgeneMedicalInformation.com

a website provided by Celgene. Clicking ‘Continue’ will take you to a website to which this Privacy Policy does not apply. We encourage you to read the Privacy Policy of every website you visit.

To request information about a Celgene Investigational Compound, please contact a Medical Information Professional at (888)771-0141 or learn more at Celgene R&D or BolderScience.com.

Request Call Back

  • Date Format: MM slash DD slash YYYY
  • (Hours of operation: 8:30AM – 5:00PM EST, Mon-Fri, Excluding Celgene Holidays)

  • to

Celgene is now part of Bristol-Myers Squibb.

To request information about ZEPOSIA® (ozanimod), please contact a Medical Information Professional at (877)-417-1523 or learn more at BMSMedinfo.com.

Celgene is now part of Bristol-Myers Squibb.

To request information about ONUREG® (azacitadine tablets), please contact a Medical Information Professional at (877)-417-1523 or learn more at BMSMedinfo.com.